Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada

Objective  This study aimed to evaluate palivizumab (PVZ) use, trends in indications, and outcomes of respiratory illness hospitalizations (RIH) and respiratory syncytial virus hospitalizations (RSVH). Study Design  It involves a large, Canadian prospective (2005–2017) observational multicenter stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Ian, Li, Abby, Bjornson, Candice L., Lanctot, Krista L., Paes, Bosco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643049/
https://www.ncbi.nlm.nih.gov/pubmed/33657636
http://dx.doi.org/10.1055/s-0041-1725146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643049/
https://www.ncbi.nlm.nih.gov/pubmed/33657636
http://dx.doi.org/10.1055/s-0041-1725146

Ejemplares similares